Today, BD is scaling up our response to disease pandemics in the developing world by focusing efforts in four key areas: increasing access to critically needed technologies, building healthcare capacity, investing in new technologies, and supporting volunteerism and philanthropy.

Collaborating across the private and public sectors, BD programs focus on creating sustainable approaches to HIV/AIDS, tuberculosis (TB), and malaria.

Good Laboratory Practices

Helping to improve laboratory skills and the quality of care in resource-limited settings.*


Collaborating across the private and public sectors to create effective and sustainable programs that help build healthcare capacity worldwide.

BD Biosciences provides flow cytometers, reagents, tools, and a wide range of services to support the work of researchers and clinicians who understand disease and improve care.

© 2019 BD. All rights reserved. Unless otherwise noted, BD, the BD Logo, and all other trademarks are property of Becton, Dickinson and Company.